04. - 08.02.2017 - SLAS 2017 6th Annual Conference & Exhibition, Washington DC, USA

SLAS2017

GravityTRAP™ 384 Microtissue Platform | SLAS2017 Conference Planner | Get 3D Screening InSight

The annual conference of the Society of Laboratory Automation and Screening (SLAS) is where science research and development professionals gather to learn about the latest and greatest laboratory tools and technologies available and how they are being applied by their peers. InSphero scientists will be available to discuss 3D screening technologies at SLAS2017 Booth #213.

 

384 reasons to talk to InSphero at SLAS2017

GravityTRAP 384 Microtissue Platform

This year, InSphero will be previewing our new GravityTRAP™ 384 Microtissue Platform, which is engineered to:

  • Enhance high content imaging quality with a continuous, flat bottom glass base plate, and a black-walled body to eliminate fluorescent crosstalk between wells
  • Prevent unintended microtissue aspiration during medium exchange with distinct culture and media chambers featuring our unique SureXchange™ ledge
  • Simplify microtissue localization, observation, and ROI identification with standard 1 mm diameter observation chambers

Starting in 2017, InSphero will begin delivering 3D InSight™ Microtissues in our GravityTRAP™ 384 format, which is ideal for HTS applications such as:

See for yourself at SLAS2017!

Stop by Booth #213 to learn more about 3D InSight™ Microtissues, view our in-booth poster hall, and This email address is being protected from spambots. You need JavaScript enabled to view it. to receive exclusive pre-launch GravityTRAP™ 384 product announcements.

Watch VideoDownload reminder card 

 

Your 3D InSight™ Conference Planner

Conference Dates 
February 4–8, 2017

Venue
Walter E. Washington Convention Center
801 Mt Vernon Pl NW, Washington, DC 20001, USA

Booth
Meet InSphero 3D microtissue experts at Booth #213

Schedule
SLAS2017 Event Scheduler

 

InSphero Educational Events

Saturday, February 4, 8:30 AM – 4:30 PM 

Dr. Jens M. Kelm

Short Course: 3D Cell-Based Assays for Drug De-Risking

Instructors: Dr. Jens M. Kelm, InSphero; Dr. Helena Hogberg, CAAT/Johns Hopkins University; Dr. Terry Riss, Promega Corp.

Cell-based in vitro assays are used throughout the drug discovery and development chain, allowing for high throughput efficacy but also mechanistic-based toxicity testing. A big challenge however is the translation of in vitro assays towards the in vivo outcome. Physiological relevance is a key parameter to improve the predictive power of cell-based assays. The better we can reflect tissue architecture, composition and function the more predictive an in vitro assay will become. The 3D course covers advances in 3D cell culture technologies, assays and their use in drug discovery and development.

View the Course Outline or Register Online


Tuesday, February 7, 1 – 3 PM

Dr. Jens M. Kelm

Poster #1298: Assessment of tumor recurrence with an in vitro 3D tumor microtissue model

Authors: Drs. Sumeer Dhar, David Fluri, and Jens M. Kelm

Short Abstract: Here we present a novel in vitro tumor relapse assay method based on a 3-dimensional tumor microtissue model, to enable compound classification based on their efficiency to prevent tumor relapse.  Read more...

 

Get 3D Screening InSight

InSphero can help you begin or advance your screening in physiologically relevant 3D models for toxicology, diabetes, and oncology. Our microtissue technology experts will be at SLAS2017, and we’d love to talk to you about how you can gain 3D InSight™ using our products and services:

Company video

company-video-inspheor